Overview

The Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI)

Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
To investigate the efficacy and safety of donepezil in individuals with mild cognitive impairment on measures of cognition, global function and behavior.
Phase:
Phase 4
Details
Lead Sponsor:
Eisai Inc.
Collaborator:
Pfizer
Treatments:
Donepezil